loadpatents
Patent applications and USPTO patent grants for Heim-Riether; Alexander.The latest application filed is for "amylin analogues".
Patent | Date |
---|---|
Amylin analogues Grant 11,382,956 - Mathiesen , et al. July 12, 2 | 2022-07-12 |
Amylin Analogues App 20210346468 - MATHIESEN; Jesper Mosolff ;   et al. | 2021-11-11 |
Amylin Analogues App 20200188485 - MATHIESEN; Jesper Mosolff ;   et al. | 2020-06-18 |
Amylin Analogues App 20190134159 - MATHIESEN; Jesper Mosolff ;   et al. | 2019-05-09 |
Amylin analogues Grant 10,071,140 - Mathiesen , et al. September 11, 2 | 2018-09-11 |
Amylin Analogues App 20180071366 - MATHIESEN; Jesper Mosolff ;   et al. | 2018-03-15 |
Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase Grant 9,139,567 - Heim-Riether , et al. September 22, 2 | 2015-09-22 |
Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them Grant 8,859,814 - Cogan , et al. October 14, 2 | 2014-10-14 |
Arylpyrazole Ethers As Inhibitors Of Leukotriene A4 Hydrolase App 20140221373 - Heim-Riether; Alexander ;   et al. | 2014-08-07 |
Heteroaryl substituted indole compounds useful as MMP-13 inhibitors Grant 8,785,489 - Abeywardane , et al. July 22, 2 | 2014-07-22 |
Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S Grant 8,729,114 - Burke , et al. May 20, 2 | 2014-05-20 |
Compounds Grant 8,674,113 - Priepke , et al. March 18, 2 | 2014-03-18 |
Heteroaryl diamide compounds useful as MMP-13 inhibitors Grant 8,637,550 - Farrow , et al. January 28, 2 | 2014-01-28 |
2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 Grant 8,586,748 - Abeywardane , et al. November 19, 2 | 2013-11-19 |
Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides Grant 8,552,205 - Barbosa, Jr. , et al. October 8, 2 | 2013-10-08 |
Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S App 20130158018 - Burke; Michael J. ;   et al. | 2013-06-20 |
Fused heteroaryl diamide compounds useful as MMP-13 inhibitors Grant 8,338,367 - Heim-Riether , et al. December 25, 2 | 2012-12-25 |
CCR10 antagonists Grant 8,299,123 - Dey , et al. October 30, 2 | 2012-10-30 |
Novel Compounds App 20120149676 - PRIEPKE; Henning ;   et al. | 2012-06-14 |
4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use Grant 8,093,245 - Augeri , et al. January 10, 2 | 2012-01-10 |
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer Grant 8,093,246 - Augeri , et al. January 10, 2 | 2012-01-10 |
2-sulfonylamino-4-heteroaryl Butyramide Antagonists Of Ccr10 App 20110275800 - Abeywardane; Asitha ;   et al. | 2011-11-10 |
Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors App 20110275625 - Farrow; Neil Alexander ;   et al. | 2011-11-10 |
Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors App 20110275631 - Abeywardane; Asitha ;   et al. | 2011-11-10 |
Alpha-substituted N-sulfonyl Gylcine Amides Antagonists Of Ccr10, Compositions Containing The Same And Methods For Using Them App 20110275612 - Cogan; Derek ;   et al. | 2011-11-10 |
Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors App 20110269668 - Heim-Riether; Alexander ;   et al. | 2011-11-03 |
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES App 20110224188 - Barbosa; Antonio Jose del Moral ;   et al. | 2011-09-15 |
Ccr10 Antagonists App 20110039851 - Dey; Kaka ;   et al. | 2011-02-17 |
4-amino-1h-pyrimidin-2-one Based Compounds, Compositions Comprising Them And Methods Of Their Use App 20080182847 - Augeri; David J. ;   et al. | 2008-07-31 |
O-linked Pyrimidin-4-amine-based Compounds, Compositions Comprising Them, And Methods Of Their Use To Treat Cancer App 20080146571 - Augeri; David J. ;   et al. | 2008-06-19 |
Methods for synthesizing imidazotriazinones App 20060264624 - Heim-Riether; Alexander ;   et al. | 2006-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.